Hermetica Superfood Encyclopedia
Solanum nigrum contains steroidal saponins and alkaloids that demonstrate anti-inflammatory and potential antitumor properties in laboratory studies. The phenolic compounds quercetin and kaempferol provide antioxidant activity through free radical scavenging mechanisms.


Kakamachi (Solanum nigrum) is a small herbaceous plant in the nightshade family native to tropical and subtropical regions. The plant's berries, leaves, and aerial parts are harvested and typically dried, then processed into powders, decoctions, or alcoholic extracts for therapeutic use.
The available research consists primarily of in vitro and in vivo pharmacological studies demonstrating therapeutic potential. No human clinical trials, randomized controlled trials, or meta-analyses with PubMed PMIDs were found in the research dossier provided.

No clinically studied dosage ranges are available from human trials. Traditional preparations include dried powder, decoctions, and alcoholic extracts, but specific therapeutic doses have not been established through clinical research. Consult a healthcare provider before starting any new supplement.
Kakamachi (Solanum nigrum) is valued in Ayurveda primarily as a medicinal herb rather than a significant dietary calorie source. Per 100 g of fresh edible leaves (commonly consumed in some traditional diets): Moisture ~80–85 g; Protein ~3.2–5.3 g; Fat ~0.5–1.0 g; Crude fiber ~1.5–2.5 g; Carbohydrates ~6–10 g; Energy ~40–55 kcal. Key micronutrients: Calcium ~210–410 mg; Iron ~4.0–10.0 mg; Phosphorus ~35–70 mg; Vitamin C (ascorbic acid) ~20–40 mg; Beta-carotene (provitamin A) ~2.0–3.5 mg; modest levels of B-vitamins including riboflavin (~0.16–0.59 mg) and niacin (~0.5–1.0 mg). Bioactive compounds (whole plant, concentrations vary by plant part and preparation): Steroidal glycoalkaloids — solasonine (~0.01–0.1% dry weight), solamargine (~0.01–0.1% dry weight), solanine (trace to low amounts in ripe berries, higher in unripe green berries); Steroidal saponins — diosgenin and related sapogenins (variable, typically <0.5% dry weight in berries); Phenolic acids — gallic acid, caffeic acid, protocatechuic acid (collectively ~50–200 mg GAE/100 g dry weight depending on extraction); Flavonoids — quercetin (~5–25 mg/100 g dry weight), kaempferol (~2–15 mg/100 g dry weight), rutin (~10–50 mg/100 g dry weight); Anthocyanins present in ripe black berries (delphinidin, malvidin, petunidin glycosides; concentration not precisely standardized but contributes to antioxidant capacity); Polysaccharides with reported immunomodulatory activity isolated from fruit; Coumarins and tannins in minor quantities. Bioavailability notes: Glycoalkaloids (solasonine, solamargine) have low oral bioavailability due to poor gastrointestinal absorption and hepatic first-pass metabolism, though they can be hydrolyzed by gut flora to more absorbable aglycones (solasodine). Flavonoid glycosides (e.g., rutin) require deglycosylation in the colon for absorption of the aglycone (quercetin), resulting in delayed but moderate bioavailability (~2–5% for quercetin from rutin). Iron content is primarily non-heme and its absorption (~5–12%) is enhanced by concurrent vitamin C present in the leaves. Fat-soluble beta-carotene bioavailability is improved when consumed with dietary fat. Calcium bioavailability may be reduced by the presence of oxalates (reported in Solanum spp. leaves). CAUTION: Unripe green berries contain significantly higher glycoalkaloid concentrations (potentially toxic above ~2–5 mg/kg body weight total glycoalkaloids) and should not be consumed; ripe black berries and properly prepared/cooked leaves have substantially reduced alkaloid content and are traditionally considered safe in moderate dietary amounts.
Solanum nigrum's steroidal saponins modulate inflammatory pathways by inhibiting pro-inflammatory cytokines and reducing oxidative stress markers. The phenolic compounds quercetin and kaempferol scavenge free radicals and chelate metal ions. Steroidal alkaloids may interact with cellular signaling pathways involved in tumor cell proliferation and apoptosis.
Current evidence for Solanum nigrum is limited to in vitro and animal studies, with no published human clinical trials. Molecular docking studies have demonstrated binding affinity of phenolic compounds to antioxidant enzymes. Animal studies suggest anti-inflammatory effects, but sample sizes are typically small (n=6-12 per group). The antitumor activity remains speculative based solely on laboratory cell culture experiments.
Solanum nigrum contains solanine and other potentially toxic alkaloids that can cause gastrointestinal distress, neurological symptoms, and hemolysis at high doses. It may interact with medications metabolized by cytochrome P450 enzymes. Pregnant and breastfeeding women should avoid use due to potential teratogenic effects. Individuals with nightshade allergies should exercise caution as cross-reactivity may occur.